Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
PHAGE: Therapy, Applications, and Research is Scopus-indexed (Q3, CiteScore 3.4), WoS ESCI. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 2641-6530Verify ISSN ↗2641-6549Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Microbiology (medical) | 85 / 147 | 42nd | Q3 |
| Virology | 51 / 86 | 41st | Q3 |
| Applied Microbiology and Biotechnology | 83 / 134 | 38th | Q3 |
| Microbiology | 135 / 194 | 30th | Q3 |
| Molecular Biology | 301 / 414 | 27th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present (also 2015), best quartile Q3, CiteScore 3.4.
PHAGE: Therapy, Applications, and Research is Q3 in Microbiology (medical) (rank 85 of 147), Q3 in Virology (rank 51 of 86) and Q3 in Applied Microbiology and Biotechnology (rank 83 of 134), by CiteScore 2025. It is ranked in 5 subject areas in all.
PHAGE: Therapy, Applications, and Research is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.4, which places it in quartile Q3 at the 42nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.462, quartile Q3, with an H-index of 17.
PHAGE: Therapy, Applications, and Research is published by SAGE Publications Ltd. Its print ISSN is 2641-6530 and its online ISSN is 2641-6549.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
PHAGE: Therapy, Applications, and Research has an h-index of 20 and a 2-year mean of 1.93 citations per paper (OpenAlex). Its Scopus CiteScore is 3.4, quartile Q3. On 2-year citations it ranks #78 of 144 Scopus journals in Microbiology (medical).
PHAGE: Therapy, Applications, and Research published 45 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2023–2026), authors are most often from United States (18.2%), United Kingdom (12.1%) and India (7.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.